Clinical Report: A Case for Reframing ‘Skin of Color’
Overview
The term 'skin of color' (SOC) has evolved but may obscure important clinical differences among patients. Authors propose a more nuanced approach to SOC, emphasizing the need for specificity in clinical contexts to enhance individualized care.
Background
The Fitzpatrick scale inadequately addresses the diversity of skin types, particularly for darker skin tones. As dermatology progresses towards personalized care, understanding the limitations of SOC is crucial for improving patient outcomes. The authors advocate for a framework that separates SOC into distinct components to better inform clinical practice.
Data Highlights
No numerical data provided in the article.
Key Findings
The Fitzpatrick scale was not originally designed for darker skin types.
The term 'skin of color' can imply various factors, leading to potential clinical imprecision.
Authors propose separating SOC into pigment phenotype, ancestry, sociocultural context, and clinical risk modifiers.
Tools for measuring pigment phenotype remain underused in clinical practice.
Clarifying the relevant dimension of SOC in clinical contexts can enhance individualized care.
Clinical Implications
Clinicians should avoid using 'skin of color' as a blanket term and instead specify which aspect of SOC is relevant in patient assessments. Incorporating tools for measuring pigment phenotype can improve treatment strategies and outcomes for patients with diverse skin types.
Conclusion
Refining the use of 'skin of color' in dermatology can enhance clinical precision and equity. A more granular approach will support individualized care and better address the needs of diverse patient populations.
Screening data from a UK clinical trial found low vitamin D levels in 55% of older patients and 72% of ethnic patients, with little variation despite summer months.
